Zacks Research Issues Negative Estimate for CLB Earnings

Core Laboratories Inc. (NYSE:CLB - Free Report) - Equities researchers at Zacks Research cut their Q3 2025 earnings estimates for shares of Core Laboratories in a research note issued to investors on Friday, May 23rd. Zacks Research analyst R. Department now anticipates that the oil and gas company will post earnings of $0.18 per share for the quarter, down from their previous estimate of $0.20. The consensus estimate for Core Laboratories' current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories' Q4 2025 earnings at $0.20 EPS, FY2025 earnings at $0.71 EPS, Q2 2026 earnings at $0.19 EPS, Q3 2026 earnings at $0.23 EPS, FY2026 earnings at $0.88 EPS and Q1 2027 earnings at $0.23 EPS.

CLB has been the topic of several other reports. Citigroup lowered their price target on shares of Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 13th. Stifel Nicolaus reduced their target price on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a report on Tuesday, April 15th. Finally, Wall Street Zen downgraded shares of Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $15.00.

Core Laboratories Price Performance

Shares of Core Laboratories stock traded up $0.36 on Monday, hitting $11.21. The company's stock had a trading volume of 399,985 shares, compared to its average volume of 405,660. Core Laboratories has a 52-week low of $10.14 and a 52-week high of $25.13. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49. The firm has a fifty day moving average price of $12.45 and a 200-day moving average price of $16.03. The company has a market capitalization of $525.56 million, a P/E ratio of 16.98, a price-to-earnings-growth ratio of 0.99 and a beta of 1.45.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). The firm had revenue of $123.59 million for the quarter, compared to analysts' expectations of $125.09 million. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. Core Laboratories's revenue was down 4.7% compared to the same quarter last year. During the same period last year, the firm earned $0.19 EPS.

Institutional Trading of Core Laboratories

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Assetmark Inc. bought a new stake in Core Laboratories in the fourth quarter valued at about $26,000. Smartleaf Asset Management LLC increased its stake in Core Laboratories by 173.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock valued at $35,000 after purchasing an additional 1,293 shares during the last quarter. AlphaQuest LLC increased its stake in Core Laboratories by 265,800.0% during the first quarter. AlphaQuest LLC now owns 2,659 shares of the oil and gas company's stock valued at $40,000 after purchasing an additional 2,658 shares during the last quarter. Nisa Investment Advisors LLC grew its position in shares of Core Laboratories by 2,688.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock valued at $42,000 after buying an additional 2,339 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its position in shares of Core Laboratories by 843.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company's stock valued at $57,000 after buying an additional 2,936 shares during the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date is Monday, May 5th. Core Laboratories's payout ratio is 6.78%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.